Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
5
×
life sciences
national blog main
rna interference
boston
alnylam pharmaceuticals
fda
national top stories
san francisco blog main
san francisco top stories
aminolevulinic acid
arrowhead pharmaceuticals
biotech
deals
drugs
eli lilly
givosiran
indiana blog main
indiana top stories
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
a2 biotherapeutics
accelerated approval
acute hepatic porphyria
acute hepatic porphyrias
aduro biotech
agency
akcea therapeutics
akili interactive labs
akin akinc
What
rnai
5
×
alnylam
drug
interference
medicine
pharmaceuticals
rna
ago
fda
gets
ok
second
seek
speedy
abandoning
afternoon
alliance
alnylam’s
approval
approved
baggage
bio
bristol
buy
calls
changing
cleared
color
companies
crispr
cuts
data
days
deal
development
dicerna
far
free
growing
history
Language
unset
Current search:
rnai
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug